# Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease

> **NCT06392061** · NA · UNKNOWN · sponsor: **Lebanese University** · enrollment: 50 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Quality of Life
- Food Intolerance
- Flare Up
- Ulcerative Colitis
- Crohn Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Trilac

## Key facts

- **NCT ID:** NCT06392061
- **Lead sponsor:** Lebanese University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06392061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06392061, "Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06392061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*